IMU Biosciences Adopts Curiox's Pluto for Large-Scale UK Immune Profiling Initiative
Leading AI-Powered Immune Profiling Company IMU to Adopt Pluto Workstation for Large-Scale Immune Phenotyping Project Based on UK Patient Big Data
SEOUL, South Korea, May 15, 2025 (GLOBE NEWSWIRE) -- Curiox Biosystems Co., Ltd. ('Curiox') announced on March 28 that it has officially received a Sales Order for its Pluto Workstation ('Pluto') from IMU Biosciences ('IMU'), a UK based techbio company decoding the immune system to drive next generation health outcomes. Following this initial purchase, IMU is expected to expand the number of Pluto units it deploys.
Dr. Nori Ueno, Vice President of Sales at Curiox, commented:, 'IMU's decision to adopt Pluto is a strong validation of the commercial and technological value of our Pluto Wash platform. As demand for AI/ML-driven analysis and automation continues to expand across life sciences, Pluto will play a central role in accelerating precision research and strengthening institutional competitiveness.' He added, 'As the only automation solution capable of replacing manual, centrifuge-based workflows in cell analysis, Pluto is well-positioned to meet unmet market needs and expand its global footprint.'
IMU is a core participant in the MANIFEST consortium (Multiomic ANalysis of Immunotherapy Features Evidencing Success and Toxicity), a UK-wide initiative launched with support from the UK government and industry partners, with a total funding of approximately £21.9 million. Within the consortium, IMU is leading precision analyses of immune responses to cancer immunotherapies and is specifically responsible for a large-scale immune phenotyping project involving blood samples from UK patients. This positions IMU as a key member of the largest immune profiling consortium ever established in the UK.
To support this monumental effort, IMU selected Curiox's Pluto Workstation as a key automation platform. Pluto addresses common pain points in sample preparation by eliminating human error and enhancing reproducibility—challenges inherent in traditional manual workflows. By enabling consistent and quantitative sample preparation, Pluto significantly improves the quality of input data, which is critical for IMU's AI/ML-based immune profiling analytics. The decision to adopt Pluto followed a highly successful demo conducted by Curiox.
Pluto's integration into IMU's workflow represents a critical enabler for scalable, high-throughput immune profiling, ensuring that AI-based insights are powered by the highest-quality input data—turning automation into a foundation for future biomedical innovation
As AI/ML-powered precision analysis becomes increasingly vital across the biomedical and healthcare sectors, including immunotherapy, demand for automation solutions that ensure data quality and standardization has become essential. IMU's selection of Pluto reflects this growing trend and positions Curiox as a key enabler of the next generation of immune profiling.
Notes
The MANIFEST consortium
The MANIFEST consortium is a four-year national research initiative led by the Francis Crick Institute and the Royal Marsden NHS Foundation Trust. It brings together 15 academic institutions—including the Cancer Research UK National Biomarker Centre—six NHS Trusts, 11 industry partners including IMU, and various patient advocacy groups and research networks.
Funded by £9 million from the UK Medical Research Council and the Office for Life Sciences, and an additional £12.9 million in matching industry contributions, the project aims to overcome key challenges in cancer immunotherapy. Its focus is to uncover predictive biomarkers linked to treatment response, resistance, and immune-related adverse events.
IMU Biosciences
IMU's goal is to revolutionise the way immune-related diseases are understood, diagnosed and treated. It is pioneering advanced immune profiling and analysis techniques to decode the human immune system and its relationship to disease.
Starting with a simple blood sample and building human immune profiles which extend from the molecular to the population level, IMU has created the world's largest and highest-resolution immune dataset. This novel platform applies proprietary immune analysis and machine learning to decode immune variation and its disease association at an unprecedented depth and scale.
By mapping the immune system of individuals at the molecular, cellular and system level and aggregating immune profiles from tens of thousands of people, IMU translates this into population-level insights, unlocking an unparalleled understanding of immune-driven health and disease.
These clinically actionable insights are enabling IMU to uncover new immune mechanisms and deliver precision approaches for diagnosing, monitoring and treating disease, prescribing the safest and most pertinent medicines and enabling the development of next generation therapies.
Built by a team of immune specialists and technologists based on a decade of research at King's College London and the Francis Crick Institute.
About Curiox Biosystems Co. Ltd
Curiox Biosystems Co. Ltd is a rapidly growing global biotechnology company specializing in advanced sample preparation solutions that enhance next-generation therapies. The company leverages expertise in surface chemistry and instrumentation to address life-science research challenges, particularly in miniaturization and automation. Curiox's innovative technologies boost productivity through sample preparation automation, speeding up therapeutic development. Committed to advancing its proprietary C-FREE™ technology, Curiox enables significant scientific breakthroughs, reinforcing its role as a key player in transforming life sciences research and diagnostics worldwide.
For more information, visit https://www.curiox.com/ or contact:
Melvin LyeSenior Director of Scientific Affairsmelvin@curiox.com +16509221219
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
The Memory Breath Introduces 3-Second Breathing Technique Inspired by Scientific Research on Mindful Focus
Dr. Brian Johnson Introduces Digital Breathing Program Aimed at Enhancing Mindful Focus Houston, June 06, 2025 (GLOBE NEWSWIRE) -- New non-invasive routine designed to promote clarity through breathwork Dr. Brian Johnson, a neuroscientist focused on sensory wellness innovation, today introduced , a digital breathwork program designed to support mindfulness and daily focus through a guided, research-informed technique. The program is centered on a simple, repeatable breathing pattern that encourages users to take a moment of intentional stillness. Dr. Johnson developed the method as part of a broader interest in brainwave-aligned breathing exercises, with the goal of offering individuals an accessible tool for supporting cognitive engagement during daily routines. "This breathing method invites people to slow down and become more aware of their mental space," said Dr. Johnson. "Our goal was to create something practical and accessible, grounded in emerging science about the role of intentional breathwork." Delivered in digital format, The Memory Breath includes instructional guidance and supporting materials intended to help users establish a daily practice. The non-ingestible approach requires no supplements or equipment and can be performed in any environment, making it adaptable to a variety of lifestyles. The program is currently available exclusively through About The Memory BreathThe Memory Breath is a digital breathwork program created by neuroscientist Dr. Brian Johnson. It focuses on helping users establish a daily rhythm of mindful breathing through a simplified technique that promotes clarity and calm. More information is available at MEDIA CONTACT INFORMATIONEmail: support@ Memory Breath Note: This press release is for informational purposes only. The information provided should not be considered medical advice. Individuals should consult with healthcare professionals before making any changes to their wellness routines. CONTACT: Email: support@
Yahoo
an hour ago
- Yahoo
Dr. Louis Krenn Medical Scholarship Invites Aspiring Physicians to Shape the Future of Healthcare
Dr. Louis Krenn SPRINGFIELD, Mo., June 06, 2025 (GLOBE NEWSWIRE) -- The Dr. Louis Krenn Medical Scholarship announces a new opportunity for undergraduate and medical students across the United States to advance their journey toward a career in medicine. This prestigious one-time award, established by Dr. Louis Krenn, a distinguished Family Medicine physician, aims to support the next generation of healthcare professionals who demonstrate a commitment to service, innovation, and compassion. The scholarship, open to students nationwide, invites applicants to share their vision for the future of medicine through a thought-provoking essay. The Dr. Louis Krenn Medical Scholarship seeks to recognize students who view medicine as more than a profession but as a calling to make a meaningful impact. Eligible applicants must be current undergraduate or medical students in the United States actively pursuing a career in medicine, either on a pre-med or medical school track. To apply, candidates are required to submit an original essay of 500–800 words responding to the prompt: 'Medicine is more than a career—it's a calling. What inspired you to pursue a path in healthcare, and how do you hope to shape the future of medicine through your work?' Essays will be evaluated based on originality, depth of reflection, and alignment with the values of service, innovation, and compassion that define Dr. Louis Krenn's legacy. Dr. Louis Krenn, a seasoned physician with over two decades of experience, established this scholarship to inspire and support students who share his dedication to advancing healthcare. Dr. Louis Krenn has held various leadership roles, including Medical Director of Ambulatory Clinical Efficiency, Chief Medical Information Officer, and Director of Telehealth. His work has focused on improving clinical workflows and expanding telehealth access, reflecting his commitment to innovation in patient care. Beyond his clinical and leadership roles, Dr. Louis Krenn is a passionate educator, having mentored countless medical, nursing, and physician assistant students. The scholarship reflects his mission to foster the growth of future physicians who will lead with compassion and drive progress in the medical field. The application process is straightforward, encouraging students to articulate their motivations and aspirations in healthcare. The deadline for submissions is March 15, 2026, with the winner announced on April 15, 2026. The selected recipient will receive a one-time award to support their educational journey. Detailed application instructions and eligibility criteria are available at The Dr. Louis Krenn Medical Scholarship stands as a testament to the importance of nurturing talent in healthcare. By offering this opportunity, the scholarship aims to encourage students to pursue their dreams in medicine while contributing to a brighter, more compassionate future for the industry. Interested applicants are encouraged to visit the official website to learn more and submit their essays. This initiative not only honors Dr. Louis Krenn's contributions to medicine but also invests in the potential of students who will shape the healthcare landscape for years to come. About the Dr. Louis Krenn Medical Scholarship The Dr. Louis Krenn Medical Scholarship is dedicated to supporting undergraduate and medical students pursuing careers in medicine. Founded by Dr. Louis Krenn, the scholarship promotes the values of service, innovation, and compassion in healthcare, aiming to inspire the next generation of physicians to make a lasting impact. For more information, please contact: Spokesperson: Dr. Louis Krenn Organization: Dr. Louis Krenn Scholarship Website: Email: apply@ A photo accompanying this announcement is available at in to access your portfolio
Yahoo
an hour ago
- Yahoo
American Botanical Council Acquires Full Rights to Steven Foster Photo Library
The nonprofit now owns more than 150,000 images of 1,700+ species of medicinal and aromatic plants taken by famed photographer and herbal expert Echinacea Purpurea Passiflora Incarnata Austin, Texas, June 06, 2025 (GLOBE NEWSWIRE) -- The nonprofit American Botanical Council (ABC) announces that it has obtained ownership rights to the entire collection of medicinal and aromatic plant photographs taken by the late botanist, author, and preeminent photographer Steven Foster (1957–2022).Foster was well-known and widely respected as the author or co-author of 21 books on herbs and medicinal plants. He also wrote more than 800 articles and reviews on herbal medicine, ethnobotany, sustainable sourcing, conservation, and related subjects, including more than 100 articles and reviews in ABC's peer-reviewed journal HerbalGram. His extensive photographic library includes more than 150,000 images of more than 1,700 accurately identified medicinal and aromatic plant species. This includes Foster's photos of many native American medicinal plants, as well as other plants he encountered during his travels in countries around the world, including Argentina, Armenia, Belize, China, Costa Rica, Egypt, England, Georgia, Germany, Guatemala, Japan, Montenegro, the Netherlands, Peru, Switzerland, Trinidad and Tobago, Vietnam, and elsewhere. Foster was a member of ABC's Board of Trustees for more than 20 years and president for 10 years. He provided frequent and instrumental support for HerbalGram and served as a contributing editor, peer reviewer, and author of dozens of feature-length articles. He also contributed hundreds of medicinal plant photos from his extensive library, including at least 60 photos that appeared on the magazine's cover. His photography filled nearly every issue of HerbalGram since issue 24 in 1991. After Foster's untimely death in January 2022, ABC continued to have access to and permission to use his photos in a variety of ABC publications and communications through a special arrangement with his estate. ABC continued to feature his photos on ABC's website, in publications of the ABC-AHP-NCNPR Botanical Adulterants Prevention Program (BAPP), and in HerbalGram, ABC's monthly newsletter HerbalEGram, ABC's weekly newsletter Herbal News & Events, and other ABC publications. Now, ABC has finalized the purchase of Foster's entire digital photo library, including full rights to all of the images. Credits to Foster's photographs will now read: 'Photo by Steven Foster ©2025 ABC.' 'For more than 40 years, Steven was a close personal friend and colleague and a primary contributor to ABC's nonprofit research and educational mission, publications, and programs,' said ABC Founder and Executive Director Mark Blumenthal. 'Steven's intelligence, botanical knowledge, insightful and deeply informed writing, and his compelling photography were an integral part of the development and evolution of HerbalGram and ABC. 'It has been ABC's goal not only to provide authoritative, reliable, science-based information on herbs and medicinal plants, but also to show the beauty of these plants, which we have done for decades thanks in large part to Steven's incredibly beautiful photos,' Blumenthal added. 'Now, ABC has the opportunity to continue its nonprofit educational mission with Steven's photos and to help expand the herb community and general public's awareness of and appreciation for Steven's remarkable photographic legacy. ABC Art Director Matt Magruder said: 'Securing the ownership of Steven Foster's photography library is an exciting new chapter for HerbalGram and all of ABC's various programs and publications. Steven's photography has been a foundational — and visually stunning — part of the organization from early on. As a fellow photographer, I am grateful to be able to honor Steven and to continue to share his quintessential photographic legacy through ABC's stewardship moving forward.' Michael J. Balick, PhD, member of ABC's Board of Trustees and vice president for botanical science, director and senior philecology curator of the Institute of Economic Botany at the New York Botanical Garden, said: 'I was delighted to learn that ABC has acquired the Steven Foster Photo Library. Steven's 'plant's eye view' was nothing short of extraordinary, and this is reflected in all of the artistic and scientific work that he did over so many decades. He was enthusiastic and generous about sharing his talents as a photographer and providing his guidance to anyone who asked for his advice, regardless of their level of botanical sophistication. When I invited him to illustrate the third edition of the Handbook of Poisonous and Injurious Plants [Springer, 2017], he provided his best work, and the photos that grace the pages of this reference book are not only useful for identification in cases of suspected poisoning, but also works of beautifully composed botanical art. We all miss Steven, who left us prematurely, and I am grateful to ABC and its donors for ensuring that this part of his legacy will endure, educating and captivating us all for many more decades.' Blumenthal noted that, at a time when people are beginning to use artificial intelligence as a source for botanical images, one primary benefit of Foster's photographs is the reliable and accurate identification of the depicted plant species. As an expert botanist, Foster properly identified the botanicals in his photos. Aside from the beauty of the photos, this benefit is a key feature of ABC's Steven Foster Photo Library. ABC featured a memorial tribute to Steven Foster in HerbalGram issue 133 and a pictorial of some of his medicinal plant photography in issue 134. A new pictorial of Foster's brilliant medicinal plant photos was just published in the current issue of HerbalGram, issue 143. In addition, ABC has named its newest award for botanical excellence after Foster, the ABC Steven Foster Excellence in Botanical Conservation and Sustainability Award, which is announced each spring at the annual ABC Celebration at Natural Products Expo West in Anaheim. Attachments Echinacea Purpurea Passiflora Incarnata CONTACT: Public Relations American Botanical Council 512-926-4900 ext. 129 publicrelations@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
